Fontalba Ana, Fernandez-L Africa, García-Alegria Eva, Albiñana Virginia, Garrido-Martin Eva M, Blanco Francisco J, Zarrabeitia Roberto, Perez-Molino Alfonso, Bernabeu-Herrero Maria E, Ojeda Maria-Luisa, Fernandez-Luna Jose L, Bernabeu Carmelo, Botella Luisa M
Centro de Investigaciones Biologicas, CSIC, Ramiro de Maeztu, 9, Madrid 28040, Spain.
BMC Med Genet. 2008 Aug 1;9:75. doi: 10.1186/1471-2350-9-75.
Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant and age-dependent vascular disorder characterised mainly by mutations in the Endoglin (ENG) or activin receptor-like kinase-1 (ALK1, ACVRL1) genes.
Here, we have identified 22 ALK1 mutations and 15 ENG mutations, many of which had not previously been reported, in independent Spanish families afflicted with HHT.
We identified mutations in thirty-seven unrelated families. A detailed analysis of clinical symptoms was recorded for each patient analyzed, with a higher significant presence of pulmonary arteriovenous malformations (PAVM) in HHT1 patients over HHT2. Twenty-two mutations in ALK1 and fifteen in ENG genes were identified. Many of them, almost half, represented new mutations in ALK1 and in ENG. Missense mutations in ENG and ALK1 were localized in a tridimensional protein structure model.
Overall, ALK1 mutations (HHT2) were predominant over ENG mutations (HHT1) in our Spanish population, in agreement with previous data from our country and other Mediterranean countries (France, Italy), but different to Northern Europe or North America. There was a significant increase of PAVM associated with HHT1 over HHT2 in these families.
遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性且与年龄相关的血管疾病,主要特征为内皮糖蛋白(ENG)或激活素受体样激酶1(ALK1,ACVRL1)基因发生突变。
在此,我们在患有HHT的西班牙独立家族中鉴定出22个ALK1突变和15个ENG突变,其中许多突变此前未曾报道。
我们在37个无亲缘关系的家族中鉴定出突变。对每位分析的患者记录了详细的临床症状,HHT1患者中肺动静脉畸形(PAVM)的发生率显著高于HHT2患者。鉴定出22个ALK1突变和15个ENG基因的突变。其中许多突变,几乎一半,代表ALK1和ENG中的新突变。ENG和ALK1中的错义突变定位在三维蛋白质结构模型中。
总体而言,在我们的西班牙人群中,ALK1突变(HHT2)比ENG突变(HHT1)更常见,这与我国和其他地中海国家(法国、意大利)的先前数据一致,但与北欧或北美不同。在这些家族中,与HHT1相关的PAVM显著多于HHT2。